A Cause-Effect Relationship of Infliximab and Pulmonary Embolism: A Case Report

Biological monoclonal antibodies such as infliximab have significantly remodeled inflammatory bowel disease's treatment course. Despite multiple side effects reported with infliximab, this medication has shown to be robust and practical. There is a paucity of cases reporting venous thromboembol...

Descripción completa

Detalles Bibliográficos
Autores principales: Bala, Areeg, Barbarawi, Mahmoud, Sidahmed, Shima, Kanugula, Ashok Kumar, Bachuwa, Ghassan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478590/
https://www.ncbi.nlm.nih.gov/pubmed/32923216
http://dx.doi.org/10.7759/cureus.9615

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478590/
https://www.ncbi.nlm.nih.gov/pubmed/32923216
http://dx.doi.org/10.7759/cureus.9615

Ejemplares similares